2.1.3.12 HIV-positive patients are ineligible because of the potential for decreased immune response to the vaccine. 2.1.4 Recruitment Strategies This study will be listed on available websites ( www.clinicaltrials.gov , www.cancer.gov/clinicaltrials , http://clinicalstudies.info.nih.gov ) and participants will be recruited from the current patient population at NIH. 2.2 SCREENING EVALUATION Screening evaluation will be conducted within 16 days before starting treatment unless otherwise specified . 2.2.1 Clinical Evaluation • History and physical examination including vital signs (blood pressure, pulse, respiratory rate, oxygen saturation) • Height and weight • Performance status determination (see Appendix A , Section 13.1) 2.2.2 Laboratory studies To be performed at any time before protocol enrollm ent: • Confirmation of diagnosis by Laboratory of Pathology at the NIH Clinical Center. • Request of a minimum of three unstained slides for expression of brachyury.